Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
01/2001
01/02/2001US6169090 Heterocyclic compounds and their therapeutic use
01/02/2001US6169087 An enzyme inhibitor for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance, obesity, autoimmune diseases, diseases with dysfunctions of the coagulation system, allergic diseases, cancer, psoriasis
01/02/2001US6169069 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids
01/02/2001US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport
01/02/2001US6168920 Extracellular adhesive proteins
01/02/2001US6168799 β-D-glucan topical composition
01/02/2001US6168794 Compositions comprising oleum Melaleuca
01/02/2001US6168784 Block the inflammatory effects of rantes, and are useful for the treatment of asthma, allergic rhinitis, atopic dermatitis, atheroma/atherosclerosis, rheumatoid arthritis and hiv infections
01/02/2001CA2312526A1 Use of dedifferentiated plant cells
01/02/2001CA2027596C Compositions containing hyaluronic acid complexes with zinc or cobalt
01/02/2001CA2009604C Diaryl-substituted heterocyclic compounds, their preparation and drugs and cosmetics obtained therefrom
12/2000
12/28/2000WO2000078953A2 Human transport proteins
12/28/2000WO2000078952A2 Human rna metabolism proteins (rmep)
12/28/2000WO2000078941A2 Methods and products for manipulating uncoupling protein expression
12/28/2000WO2000078937A1 Methods for ameliorating icthyosiform skin diseases
12/28/2000WO2000078928A2 Surface for cell culture
12/28/2000WO2000078815A1 ANTI-αvβ3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE
12/28/2000WO2000078794A1 Cysteinyl protease inhibitors
12/28/2000WO2000078757A1 Inhibitors of il-12 production
12/28/2000WO2000078753A1 Process for the preparation of paroxetine and structurally related compounds
12/28/2000WO2000078746A1 Antiviral agents
12/28/2000WO2000078731A1 5-cyano-2-aminopyrimidine derivatives
12/28/2000WO2000078360A1 Compositions and methods for the treatment or prevention of autoimmune disorders
12/28/2000WO2000078350A1 Remedies for skin ulcer
12/28/2000WO2000078341A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000WO2000078337A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
12/28/2000WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use
12/28/2000WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses
12/28/2000WO2000078324A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof
12/28/2000WO2000078316A1 Use of nitroxides in wound healing and in the prevention of photodamage
12/28/2000WO2000078299A2 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
12/28/2000WO2000078277A1 Micropigment mixture
12/28/2000WO2000078266A2 Interferon tau mutants and methods for making them
12/28/2000WO2000078259A1 Enhanced wound coverage to enhance wound healing
12/28/2000WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands
12/28/2000WO2000055162A3 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/28/2000WO2000054780A3 Corticosteroid formulation
12/28/2000WO2000052013A3 Thiazoloindolinone compounds
12/28/2000WO2000048625A3 Inhibitors for use in hemostasis and immune function
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000043373A3 Kinase inhibitors
12/28/2000WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors
12/28/2000DE19929715A1 New 11-beta-long chain substituted estratriene derivatives, are antiestrogens or tissue-selective partial estrogens useful e.g. for treating hormone-dependent cancer or osteoporosis
12/28/2000DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
12/28/2000CA2382425A1 Interferon tau mutants and methods for making them
12/28/2000CA2377593A1 Remedies for skin ulcer
12/28/2000CA2377530A1 Compositions and methods for the treatment or prevention of autoimmune disorders
12/28/2000CA2377371A1 Enhanced wound coverage to enhance wound healing
12/28/2000CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use
12/28/2000CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000CA2376081A1 Cysteinyl protease inhibitors
12/28/2000CA2375508A1 Methods and products for manipulating uncoupling protein expression
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375236A1 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
12/28/2000CA2375211A1 Antiviral agents
12/28/2000CA2375182A1 5-cyano-2-aminopyrimidine derivatives
12/28/2000CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses
12/27/2000EP1062334A1 Mammalian sodium channel proteins
12/27/2000EP1062322A2 A living chimeric skin replacement
12/27/2000EP1062319A1 Vascular endothelial growth factor 2
12/27/2000EP1062239A2 Ribonucleotide polypeptides containing metal
12/27/2000EP1062237A1 Ribonucleotide polypeptides containing metal
12/27/2000EP1062236A1 31 human secreted proteins
12/27/2000EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
12/27/2000EP1062216A1 Inhibitors of phospholipase a2
12/27/2000EP1062214A1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1062204A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1062199A1 Modulators of protein tyrosine phosphatases (ptpases)
12/27/2000EP1061963A1 Protease inhibitors in absorbent articles
12/27/2000EP1061962A1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor
12/27/2000EP1061942A1 Topical composition containing human epidermal growth factor
12/27/2000EP1061931A2 Thrombin preparation and products and fibrin sealant methods employing same
12/27/2000EP1061916A2 Use os nitrone compounds for the inhibition of angiogenesis
12/27/2000EP1061912A1 Phenanthrofuran derivatives
12/27/2000EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2000EP1061802A1 Topical carbamazepine formulations and methods of use
12/27/2000CN1278263A 2,3-diaryl-pyrazolo [1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2 (cox-2) inhibitors
12/27/2000CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors
12/27/2000CN1278173A Skin penetration enhancing components
12/27/2000CN1277836A Novel cleaning agent component with improved characteristics of sedimentation and hair conditioning properties
12/27/2000CN1059834C Pure traditional Chinese medicinal liquor with antisenile action
12/27/2000CN1059806C Face cream for curing acne
12/27/2000CN1059804C Adhesive plaster for wound and preparation process thereof
12/27/2000CN1059803C Chinese medicine for curing hamemorrhoids inflammation
12/27/2000CN1059798C Infusion for burn and scald
12/26/2000US6166244 Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
12/26/2000US6166219 Treatment of diabetes and related disorders
12/26/2000US6166206 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
12/26/2000US6166087 Immunosuppresants, antiinflammatory agents, antitumor agents;applying to mucous membranes
12/26/2000US6166084 Compositions for the treatment of chronic wounds
12/26/2000US6166055 Antiinflammatory agents
12/26/2000US6166048 Pharmaceutical compositions for inhibition of cytokine production and secretion
12/26/2000US6166031 An inhibitor of 5-lipoxygenase enzyme, a blocking agents of leukotriene receptors; useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165996 Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis
12/26/2000US6165994 Methods for promoting the healing of cutaneous wounds and ulcers using compositions of α-D-glucans
12/26/2000US6165978 Wound healing composition
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
1 ... 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 ... 1065